With the Queensland State Government election fast-approaching, it’s important that any Queensland businesses that are considering applying for state government funding understand what impact the election will have on grant programs. We’ve summarised our analysis of the impact that elections can have on the grant funding landscape, with a particular focus on the Queensland State Government election in October.

The Medical Research Future Fund (MRFF) is a major source of health research funding in Australia, providing opportunities for both researchers and companies. The MRFF publishes funding rounds in advance, giving applicants reasonable notice to prepare. We have prepared an overview of upcoming grant opportunities, eligibility, and how Intellect Labs can support your submission.

The Overseas Finding process is a crucial component of the Research & Development Tax Incentive (RDTI) in Australia, enabling companies to access a tax benefit for overseas activities that relate to an Australian R&D program. This guide explores the Overseas Finding process, the key conditions for eligibility, and recent ATO concerns as outlined in taxpayer alerts. We also highlight a successful case study with a cyber security innovator, Internet 2.0, to illustrate effective strategies for securing an Overseas Finding.

The R&D Tax Incentive remains Australia’s primary program for supporting businesses undertaking R&D activities with an estimated $3.2 billion annual investment. The program uses a $20 million annual turnover threshold to determine a company’s R&D tax rebate, a threshold that has been unchanged since 2011. In our view, it is time to review this arbitrary line in the sand and ensure the R&DTI aligns with other SME policies so that highly innovative medium sized businesses are incentivised to continue their R&D investment as they grow.

The end of the financial year brings with it some important considerations if you’re planning to lodge an FY24 R&D Tax Incentive claim. We’ve summarised some key things you need to be across.

In its latest R&D Tax Incentive decision (GQHC v Commissioner of Taxation [2024] AATA 409) , the Administrative Appeals Tribunal (AAT) affirmed the position that the ATO has the power to assess and determine the eligibility of R&D activities per the legislative requirements.

Companies preparing R&D Tax Incentive claims need to be aware of rules that prevent “double-dipping” when they have received grants or other recoupments for the R&D activities being claimed.

An AAT decision handed down in December 2023 found activities relating to the development of a customised basketball shoe to suit the requirements of an Australian professional basketball player were neither core nor supporting activities, within the meaning of the relevant legal provisions.

The ATO is set to publish detailed information on R&D tax incentive claims submitted by R&D entities. The initiative aims to enhance transparency, shed light on the benefits derived by companies, and encourage voluntary compliance with the R&D program.